The biological magic behind the bullets
Article Abstract:
The expansion of a tool kit that studies how drugs exert the biological effects by using powerful new approach such as yeast-based global fitness test that reveals genes involved in mediating the response of yeast cells to a test compound is presented. The expectations on this tool and other chemical genetic approaches to bring insights into the mechanisms of action existing drugs are also presented.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Structure-based maximal affinity model predicts small-molecule druggability
Article Abstract:
A model-based approach that uses basic biophysical principles has yielded good prediction of druggability based on the crystal structure of the target binding site. The two predictions are tested by using high-throughput screening of a diverse compound collection and the results have highlighted the use of this approach as well as strategies for tackling difficult targets.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Growing pains in Aids drug development
Article Abstract:
University of California, San Francisco and University of New South Wales in Sydney, Australia collaborated to design an AIDS medicine Gilead. The study of Gilead was lacking with politics surrounding the groups of patients infected with HIV.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Scale and the scale effect in market-based accounting research. part 2 Discussions of the incremental information content of earnings and cash flows from operations affected by their extremity
- Abstracts: There is life beyond sell-side analysts. Nielsen defines values, society role for PR. Keep finger on pulse to maximize PR results
- Abstracts: The Cartagena Protocol and the future of agbiotech. Old dogma, new tricks-21st Century phage therapy. UK parses merits of value-based drug pricing
- Abstracts: Systems biology, incorporated? Oligo oligarchy -- the surprisingly small world of aptamers